Thank you for your interest, but it looks like you already have a Dexcom account.
Unfortunately, this program is for those who have never tried Dexcom CGM technology only and is limited to one sample per household.
Indications for Use:
The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 CGM System or G7) is a glucose monitoring system indicated for continuously measuring glucose in the interstitial fluid in persons age 2 years and older. The Dexcom G7 CGM System is designed to replace fingerstick blood glucose (BG) testing for treatment decisions. Interpretation of the Dexcom G7 CGM System results should be based on glucose trends and several sequential sensor readings over time. The Dexcom G7 CGM System also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. The Dexcom G7 CGM System is intended for use by patients at home and in healthcare facilities.
Dexcom, Dexcom Follow, Dexcom Clarity, Dexcom Share, Share, and Dexcom ONE are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and Share are trademarks or registered trademarks in the U.S. and may be in other countries.
COPYRIGHT © 2023 DEXCOM CANADA, CO. ALL RIGHTS RESERVED. This product is covered by U.S. patent.
MAT-0324